Back
Alnylam Pharmaceuticals Stock Price Chart

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
ALNY
Alnylam Pharmaceuticals
Last Price:
$268.29
Seasonality Move:
7.6%
7 Day Trial
ALL ACCESS PASS
$
7

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bullish and ALNY is experiencing slight buying pressure.
Alnylam Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 268.31 | Buy |
20-day SMA: | 253.84 | Buy |
50-day SMA: | 259.68 | Buy |
200-day SMA: | 253.36 | Buy |
8-day EMA: | 268.69 | Buy |
20-day EMA: | 260.57 | Buy |
50-day EMA: | 257.45 | Buy |
200-day EMA: | 244.33 | Buy |
Alnylam Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.53 | Buy |
Relative Strength Index (14 RSI): | 57.28 | Buy |
Chaikin Money Flow: | 106003 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (238.42 - 267) | Buy |
Bollinger Bands (100): | (240.58 - 270.64) | Buy |
Alnylam Pharmaceuticals Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 271.02 while ALNY 8-day simple moving average is 268.31, which is a Buy signal.
-
The stock price of ALNY is 271.02 while Alnylam Pharmaceuticals 20-day SMA is 253.84, which makes it a Buy.
-
Alnylam Pharmaceuticals 50-day simple moving average is 259.68 while ALNY share price is 271.02, making it a Buy technically.
-
ALNY stock price is 271.02 and Alnylam Pharmaceuticals 200-day simple moving average is 253.36, creating a Buy signal.
ALNY Technical Analysis vs Fundamental Analysis
Sell
43
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a SellThe current Alnylam Pharmaceuticals [ALNY] share price is $271.02. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
35.1B
Price in USD:
271.02
Share Volume:
984.1K
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
304.39
52-Week Low:
141.98
Sell
43
Alnylam Pharmaceuticals (ALNY)
is a Sell
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?The Alnylam Pharmaceuticals stock price is 271.02 USD today.
-
Will ALNY stock go up or go down?Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Alnylam Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 271.02 while ALNY 8-day exponential moving average is 268.69, which is a Buy signal.
-
The stock price of ALNY is 271.02 while Alnylam Pharmaceuticals 20-day EMA is 260.57, which makes it a Buy.
-
Alnylam Pharmaceuticals 50-day exponential moving average is 257.45 while ALNY share price is 271.02, making it a Buy technically.
-
ALNY stock price is 271.02 and Alnylam Pharmaceuticals 200-day simple moving average is 244.33, creating a Buy signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
-
ALNY Moving Average Covergence Divergence (MACD) indicator is 5.53, suggesting Alnylam Pharmaceuticals is a Buy
-
Alnylam Pharmaceuticals Relative Strength Index (RSI) is 57.28, which suggest Alnylam Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Alnylam Pharmaceuticals is (238.42 - 267), which suggest Alnylam Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Alnylam Pharmaceuticals is (240.58 - 270.64), which suggest Alnylam Pharmaceuticals is a Buy
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.